Antonetti Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Antonetti Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$299K	Sell	5,143 -294	-5%	-$18K	0.47%	31
2023 Q2	$348K	Buy	5,437 +6	+0.1%	+$402	0.5%	29
2023 Q1	$376K	Buy	5,431 +455	+9%	+$32.1K	0.55%	25
2022 Q4	$358K	Sell	4,976 -196	-4%	-$14.8K	0.49%	32
2022 Q3	$368K	Sell	5,172 -910	-15%	-$66K	0.42%	30
2022 Q2	$468K	Sell	6,082 -195	-3%	-$14.9K	0.49%	30
2022 Q1	$458K	Sell	6,277 -445	-7%	-$29.9K	0.43%	33
2021 Q4	$419K	Buy	6,722 +6	+0.1%	+$352	0.33%	51
2021 Q3	$397K	Buy	+6,716	New	+$442K	0.32%	46
2013 Q4	–	Sell	-2,050	Closed	-$95K	–	261
2013 Q3	$95K	Hold	2,050	–	–	0.1%	113
2013 Q2	$92K	Buy	+2,050	New	+$89K	0.1%	118

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Antonetti Capital Management's BMY Position: Q3 2023 in Review

Antonetti Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 5.4% in Q3 2023, selling an estimated $18K and leaving 5,143 shares worth $299K. The position accounts for 0.47% of the portfolio, ranked #31.

Antonetti Capital Management first reported a position in BMY in Q2 2013 and has held it in 11 quarters since. The position peaked at $468K in Q2 2022. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Antonetti Capital Management held 5,143 shares of Bristol-Myers Squibb worth $299K as of Q3 2023.
Antonetti Capital Management sold 294 Bristol-Myers Squibb shares in Q3 2023, an estimated $18K.
Bristol-Myers Squibb made up 0.47% of Antonetti Capital Management's portfolio in Q3 2023, its #31 holding.
Antonetti Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 11 quarters since.
Antonetti Capital Management's Bristol-Myers Squibb position peaked at $468K in Q2 2022.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Antonetti Capital Management's 13F filing for Q3 2023, filed 9 Nov 2023.